To Assess the Safety and Tolerability of Tafasitamab Alone or in Combination With Other Drugs in Japanese Participants With Non-Hodgkins Lymphoma (NHL) (J-MIND)
A Phase 1b/2 Study of Tafasitamab, Tafasitamab Plus Lenalidomide, Tafasitamab Plus Parsaclisib, and Tafasitamab Plus Lenalidomide in Combination With R-CHOP in Japanese Participants With Non-Hodgkin Lymphoma
Sponsor: Incyte Biosciences Japan GK
This PHASE1/PHASE2 trial investigates Diffuse Large B-cell Lymphoma and Non Hodgkins Lymphoma and is currently ongoing. Incyte Biosciences Japan GK leads this study, which shows 20 recorded versions since 2020 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
20 versions recorded-
Jan 2026 — Present [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Sep 2025 — Jan 2026 [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Aug 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE1/PHASE2
Status: Recruiting → Active Not Recruiting
-
Jan 2025 — Aug 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Dec 2024 — Jan 2025 [monthly]
Recruiting PHASE1/PHASE2
▶ Show 15 earlier versions
-
Sep 2024 — Dec 2024 [monthly]
Recruiting PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Recruiting PHASE1_PHASE2
Phase: PHASE1 → PHASE1_PHASE2
-
May 2024 — Jun 2024 [monthly]
Recruiting PHASE1
-
Mar 2024 — May 2024 [monthly]
Recruiting PHASE1
-
Oct 2023 — Mar 2024 [monthly]
Recruiting PHASE1
-
Aug 2023 — Oct 2023 [monthly]
Recruiting PHASE1
-
Dec 2022 — Aug 2023 [monthly]
Recruiting PHASE1
-
Nov 2022 — Dec 2022 [monthly]
Recruiting PHASE1
-
Sep 2022 — Nov 2022 [monthly]
Recruiting PHASE1
-
Jul 2022 — Sep 2022 [monthly]
Recruiting PHASE1
-
Feb 2022 — Jul 2022 [monthly]
Recruiting PHASE1
-
Sep 2021 — Feb 2022 [monthly]
Recruiting PHASE1
-
Mar 2021 — Sep 2021 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE1
First recorded
Dec 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Incyte Biosciences Japan GK
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aichi, Japan , Chiba, Japan , Fukui, Japan , Fukuoka, Japan , Hyōgo, Japan , Kanagawa, Japan , Kumamoto-ken, Japan , Kōtoku, Japan , Matsuyama, Japan , Miyagi, Japan and 11 more locations